DEF 14C

DEFINITIVE INFORMATION STATEMENT

Company: Inhibitor Therapeutics, Inc.
Filed: June 16, 2015
Period of Report: June 16, 2015
Accession Number: 0001193125-15-224644

View Document ↗ View on SEC.gov ↗